Search - tctmd.com

Displaying 181 - 200 of 221

Sort: Relevancy | Date

News Daily News

Deep-Learning Tool Can Gauge Plaque Burden, Stenosis Severity on CCTA

Yael L. Maxwell

March 28, 2022

News Featured Fellow

Alice Soohyun Chang, MD

Yael L. Maxwell

March 18, 2022

News CV Team Pro

Thorsten Stender, Cardiovascular Technologist

L.A. McKeown

March 15, 2022

News Daily News

Pelacarsen Targets Lp(a), With Little Impact on LDL Cholesterol

Michael O'Riordan

March 15, 2022

News Features

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

Shelley Wood

March 14, 2022

News Daily News

Thrombolysis ‘Safe and Effective’ for Obstructive Mechanical Valve Thrombosis

Yael L. Maxwell

March 09, 2022

News Conference News

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

Caitlin E. Cox

March 02, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Daily News

Female Cardiologists Still Face Pushback as Physician-Researchers

Caitlin E. Cox

February 28, 2022

News Daily News

COVID-19: TCTMD’s Dispatch for March Week 1

Todd Neale

February 28, 2022

Presentation CTO 2022

Extra-Stent Subintimal Plaque Modification; A Novel Technique to Overcome Resistant Stent Under Expansion

Presenter: Michael Megaly

February 25, 2022

News Daily News

What Can Lp(a) Add to CAC for ASCVD Risk Prediction? New Insights

Yael L. Maxwell

February 22, 2022

News Daily News

Robert M. Califf Becomes 25th Commissioner of the US FDA

L.A. McKeown

February 15, 2022

News Daily News

COVID-19: TCTMD’s Dispatch for February Week 3

Todd Neale

February 14, 2022

News Conference News ISC 2022

CHOICE: Intra-arterial tPA Enhances Benefit of Stroke Thrombectomy

Todd Neale

February 11, 2022

News Daily News

Chinese Herbal Formula Matches Losartan in Patients With Mild Hypertension

Caitlin E. Cox

February 11, 2022

Presentation THT 2022

Novel Medical Therapies for AS

Presenter: Brian Lindman

February 02, 2022

News Industry News

Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients

February 02, 2022

News Daily News

Segregation Linked to Hypertension Among Black, Hispanic Individuals

Caitlin E. Cox

February 01, 2022

Presentation THT 2022

Featured Lecture: Medical Therapies for Amyloid

Presenter: Matthew Maurer

February 01, 2022

Advertisement

Deep-Learning Tool Can Gauge Plaque Burden, Stenosis Severity on CCTA

Alice Soohyun Chang, MD

Thorsten Stender, Cardiovascular Technologist

Pelacarsen Targets Lp(a), With Little Impact on LDL Cholesterol

Aortic Valve Replacement: What’s on the Wish List for Future Devices?

Thrombolysis ‘Safe and Effective’ for Obstructive Mechanical Valve Thrombosis

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Female Cardiologists Still Face Pushback as Physician-Researchers

COVID-19: TCTMD’s Dispatch for March Week 1

Extra-Stent Subintimal Plaque Modification; A Novel Technique to Overcome Resistant Stent Under Expansion

What Can Lp(a) Add to CAC for ASCVD Risk Prediction? New Insights

Robert M. Califf Becomes 25th Commissioner of the US FDA

COVID-19: TCTMD’s Dispatch for February Week 3

CHOICE: Intra-arterial tPA Enhances Benefit of Stroke Thrombectomy

Chinese Herbal Formula Matches Losartan in Patients With Mild Hypertension

Novel Medical Therapies for AS

Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients

Segregation Linked to Hypertension Among Black, Hispanic Individuals

Featured Lecture: Medical Therapies for Amyloid

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content